OncoDNA to acquire BioSequence

Belgium-based OncoDNA, specialized in developing and marketing cancer diagnosis kits (NGS and IHCs) has acquired Spanish BioSequence, focusing on genome analysis of all cancer types by tissue examination. The parties have not provided the financial details of the transaction. OncoDNA last September received €7.7m of funding in equity by a group of investors lead by Ackermans & van Haaren.
(Source El Economista)